Safety and efficacy of trastuzumab emtansine (TDM-1) in a patient on hemodialysis for renal failure von González, A. Falcón, Garcia, P. Estévez, Gastaldo, A. Sánchez, Simón, I. Sánchez, Boffil, J. Salvador, Borrego, M. Ruiz

Volltext

180P Immunotherapy as an effective therapy approach for advanced non-small cell lung cancer (NSCLC): A single institution experience in the context of clinical trials and expanded... von Pérez, J. Martínez, González, A. Falcón, Simón, I. Sánchez, Cervera, A., García, M. Alonso, Oncala, M.J. Flor, Jiménez, I. Gallego, Maíquez, P., Gonzàlez-Serna, L. Jiménez, Corral, J.

Volltext

Trabectedin and radiotherapy in advanced sarcoma: Experience of a reference center von Carrasco Garcia, I.C., Hindi, N., Peinado, J., Rincon, I., Cordeiro, M., Jimenez, F.J., Falcon Gonzalez, A., Lasso de la Vega, R., Noguer Mediavilla, M., Sancho Marquez, P., Martin-Broto, J.

Volltext

Immunotherapy as an effective therapy approach for advanced non-small cell lung cancer (NSCLC): A single institution experience in the context of clinical trials and expanded acces... von Pérez, Martínez J, González, Falcón A, Simón, Sánchez I, Cervera, A, García, Alonso M, Oncala, Flor M.J, Jiménez, Gallego I, Maíquez, P, González-Serna, Jiménez L, Corral, J

Volltext

1889P Addressing unmet needs in the management of persistent severe cancer pain: European expert recommendations von di Palma, M., Brown, M., Padilla, M.L., Hoefing, C., Bagchi, S., Macarulla Mercade, T., Iorfida, M., Zuidema, X., Dupoiron, D., Falcon Gonzalez, A., van Keulen, D., Kortbaoui, R., Guardamagna, V., Tornero, C., Perruchoud, C.

Volltext

Assessment of the relative contribution of COX‐1 and COX‐2 isoforms to ischemia‐induced oxidative damage and neurodegeneration following transient global cerebral ischemia von Candelario‐Jalil, Eduardo, González‐Falcón, Armando, García‐Cabrera, Michel, Álvarez, Dalia, Al‐Dalain, Said, Martínez, Gregorio, León, Olga Sonia, Springer, Joe E.

Volltext

1790P Phase II data of lurbinectedin (LUR) and irinotecan (IRI) in relapsed small cell lung cancer (SCLC) patients (pts) with chemotherapy-free interval (CTFI)>30 days (d) von Zugazagoitia, J., Falcon Gonzalez, A., Navarro Mendivil, A.F., Sanchez Gastaldo, A., Simoes da Rocha, P.F., Cote, G.M., Bockorny, B., Molina Cerrillo, J., Artal, A., Baena Espinar, J., Gil Torralvo, A., Ponce Aix, S., Bote De Cabo, H., Martinez Perez, J., Martínez, S., López-Vilariño, J.A., Kahatt, C., Gómez, J., Paz-Ares, L.G.

Volltext

616MO Long-term follow-up of single-agent divarasib in patients with KRAS G12C-positive solid tumors von Garralda, E., Patel, M.R., Kim, T.W., Sacher, A.G., Forster, M.D., Santoro, A., Desai, J., Paz-Ares, L.G., Falcon Gonzalez, A., De Miguel, M., Bowyer, S.E., Dziadziuszko, R., Kim, S.H., Han, S-W., Krebs, M.G., Lorusso, P., Cosman, R., Chang, J., Jun, T., Miller, W.H.

Volltext

1769P Safety and efficacy with vimseltinib in patients (pts) with tenosynovial giant cell tumor (TGCT) who received no prior anti–colony-stimulating factor 1 (CSF1) therapy: Ongoin... von Serrano, C., Blay, J-Y., Rutkowski, P., Gelderblom, H., Stacchiotti, S., Falcon Gonzalez, A., Desai, J., Le Cesne, A., Ferraresi, V., Palmerini, E., Wilky, B.A., Wagner, A.J., Bernthal, N.M., van de Sande, M., Narasimhan, S., Harrow, B., Sharma, M.G., Ruiz-Soto, R., Sherman, M.L., Tap, W.D.

Volltext

Assessment of prognostic and therapeutic factors in men with breast cancer von Herrero Rivera, D., Morales Herrero, M.D.R., Almeida González, C., Sánchez Camacho-Mejías, A., Carrasco García, I., Benedetti Pedroza, J., Falcon Gonzalez, A., Montaño Periáñez, Á, Salvador Bofil, F.J., Ruiz Borrego, M.

Volltext

304P - Assessment of prognostic and therapeutic factors in men with breast cancer von Herrero Rivera, D., Morales Herrero, M.D.R., Almeida González, C., Sánchez Camacho-Mejías, A., Carrasco García, I., Benedetti Pedroza, J., Falcon Gonzalez, A., Montaño Periáñez, Á, Salvador Bofil, F.J., Ruiz Borrego, M.

Volltext

304PAssessment of prognostic and therapeutic factors in men with breast cancer von Herrero Rivera, D, Morales Herrero, M D R, Almeida González, C, Sánchez Camacho-Mejías, A, Carrasco García, I, Benedetti Pedroza, J, Falcon Gonzalez, A, Montaño Periáñez, Á, Salvador Bofil, F J, Ruiz Borrego, M

Volltext

459MO Phase Ia study to evaluate GDC-6036 monotherapy in patients with solid tumors with a KRAS G12C mutation von Patel, M., Lee, J-S., De Miguel, M.J., Burns, T., Falcon Gonzalez, A., Kim, T.W., Krebs, M.G., Prenen, H., Shacham Shmueli, E., Desai, J., Lorusso, P., Sacher, A., Choi, Y., Dharia, N., Lin, M.T., Mandlekar, S., Royer-Joo, S., Schutzman, J.L., Garralda, E.

Volltext

1509P Efficacy and safety of vimseltinib in tenosynovial giant cell tumour (TGCT): Phase II expansion von Blay, J-Y., Gelderblom, H., Rutkowski, P., Wagner, A., van de Sande, M., Falcon Gonzalez, A., Stacchiotti, S., Le Cesne, A., Alcindor, T., Serrano, C., Palmerini, E., Ravi, V., Casado Herraez, A., Seddon, B., Vallee, M., Jarecha, R., Sharma, M., Ruiz-Soto, R., Sherman, M.L., Tap, W.D.

Volltext

362P Phase Ia study to evaluate GDC-6036 monotherapy in patients with colorectal cancer (CRC) with KRAS G12C mutation von Desai, J., Han, S-W., Forster, M.D., Kim, T.W., Alonso Casal, G., Shacham Shmueli, E., Bowyer, S.E., De Miguel, M.J., Falcon Gonzalez, A., Jones, R.H., Krebs, M.G., Miller, W.H., Paz-Ares, L., Lorusso, P., Sacher, A., Dharia, N., Lin, M.T., Schutzman, J.L., Shi, Z., Patel, M.

Volltext

Clinical effectiveness and safety of olaparib in BRCA-mutated, HER2-negative metastatic breast cancer in a real-world setting: final analysis of LUCY von Balmaña, Judith, Fasching, Peter A., Couch, Fergus J., Delaloge, Suzette, Labidi-Galy, Intidhar, O’Shaughnessy, Joyce, Park, Yeon Hee, Eisen, Andrea F., You, Benoit, Bourgeois, Hughes, Gonçalves, Anthony, Kemp, Zoe, Swampillai, Angela, Jankowski, Tomasz, Sohn, Joo Hyuk, Poddubskaya, Elena, Mukhametshina, Guzel, Aksoy, Sercan, Timcheva, Constanta V., Park-Simon, Tjoung-Won, Antón-Torres, Antonio, John, Ellie, Baria, Katherine, Gibson, Isabel, Gelmon, Karen A.

Volltext

103P PET-CT in localized breast cancer: Does it impact on the therapeutic decision? von Rodriguez, P. Macias, Perez, R. Buezas, Cejuela, M., Gonzalez, A. Falcon, Torralvo, A. Gil, Viñuales, M. Benavent, Alvarez, R.M., Cases, C., Borrego, M. Ruiz, Bofill, F.J. Salvador

Volltext

Wide therapeutic time window for nimesulide neuroprotection in a model of transient focal cerebral ischemia in the rat von Candelario-Jalil, Eduardo, González-Falcón, Armando, Garcı́a-Cabrera, Michel, León, Olga Sonia, Fiebich, Bernd L

Volltext

1626PTrabectedin and radiotherapy in advanced sarcoma: Experience of a reference center von Carrasco Garcia, I C, Hindi, N, Peinado, J, Rincon, I, Cordeiro, M, Jimenez, F J, Falcon Gonzalez, A, Lasso de la Vega, R, Noguer Mediavilla, M, Sancho Marquez, P, Martin-Broto, J

Volltext

27O Lurbinectedin plus irinotecan in pre-treated gastroenteropancreatic neuroendocrine carcinomas (GEP-NECs) von Garcia-Carbonero, R., Cote, G.M., Le Cesne, A., Anton-Pascual, B., Gordoa, T. Alonso, Gonzalez, A. Falcon, Torralvo, A. Gil, Martinez, S., Siguero, M., Cullell, M., Fudio, S., Zeaiter, A., Cerrillo, J. Molina

Volltext